Complete Health Screening Schedule by Age – What Tests When

Adults in the U.S. should begin regular preventive screenings as early as age 18 for blood pressure and age 21 for cervical cancer. Most major chronic disease screenings, including colonoscopies and mammograms, start between ages 40 and 50. Knowing exactly which test belongs to which decade can mean catching a condition years before symptoms appear.

What Preventive Screenings Actually Are

Preventive screenings are medical tests performed on people who show no symptoms, with the goal of detecting disease early when treatment is most effective. The U.S. Preventive Services Task Force (USPSTF), a federally supported independent panel of medical experts, issues evidence-based recommendations that guide most screening schedules used by American physicians today.

Insurance coverage under the Affordable Care Act (ACA) requires most private health plans to cover USPSTF “A” and “B” rated screenings at no cost to the patient, meaning a $0 copay when the test is performed as preventive care rather than diagnostic care. This distinction matters enormously in practice: if a colonoscopy is ordered because you reported rectal bleeding, it is coded as diagnostic and subject to your deductible, not as preventive.

The three major bodies that issue screening guidance in the United States are the USPSTF, the American Cancer Society (ACS), and specialty organizations such as the American College of Cardiology (ACC), the American Diabetes Association (ADA), and the American College of Obstetricians and Gynecologists (ACOG). These organizations sometimes disagree on start ages and intervals, which is why two patients the same age may receive slightly different schedules from two equally qualified physicians.

Free online age calculator to calculate your exact age in years, months, days, hours, and minutes. Find out how old you are and when your next birthday is.

Important Concept: A “false positive” occurs when a screening test suggests disease is present when it is not, potentially leading to follow-up procedures, anxiety, and cost. A “false negative” occurs when a test misses a disease that is actually present. Every screening recommendation reflects a careful weighing of these two error types against the benefit of early detection.

The Core Logic Behind Age-Based Scheduling

Risk for most diseases increases with age, which is why screening intervals tighten and test types expand as patients move through each decade. Screening frequency is also shaped by personal risk factors, meaning family history, body mass index (BMI, a number calculated from height and weight used to estimate body fat), tobacco use, and prior test results can all shift a person’s schedule earlier or more often than the standard chart suggests.

Understanding the difference between primary prevention (stopping a disease from developing, such as vaccination) and secondary prevention (detecting a disease early before it causes symptoms, which is what most screenings accomplish) helps clarify what a screening can and cannot do. Screenings do not prevent disease; they detect it at a stage when treatment has a higher chance of success.

Sensitivity refers to a test’s ability to correctly identify people who have the disease, meaning a high-sensitivity test produces fewer false negatives. Specificity refers to a test’s ability to correctly identify people who do not have the disease, meaning a high-specificity test produces fewer false positives. No test is perfect on both measures, and this trade-off shapes every recommendation on this schedule.

Key Finding: The CDC reports that only 8% of U.S. adults aged 35 and older receive all recommended preventive services, representing a significant gap between available tools and actual use.

How Race, Ethnicity, and Genetics Shift the Standard Schedule

Standard screening ages are calculated for average-risk populations, but several racial and ethnic groups carry measurably different baseline risks that warrant adjusted timelines.

• Black Americans have the highest colorectal cancer incidence and mortality rate of any racial group in the United States. The American College of Gastroenterology recommends that Black adults begin colorectal cancer screening at age 40 rather than 45, a full 5 years earlier than the standard recommendation.
• Black women have a 40% higher breast cancer mortality rate than white women despite similar incidence rates, partly because aggressive subtypes like triple-negative breast cancer are more common. Many oncologists recommend annual mammography beginning at 40 for Black women without waiting for a family history trigger.
• Hispanic Americans have a 1.5 times higher rate of liver disease and cirrhosis, making hepatitis C and hepatitis B screening particularly important in this population.
• Asian Americans have elevated type 2 diabetes risk at lower BMI thresholds. The ADA recommends screening Asian Americans for diabetes starting at a BMI of 23 kg/m² rather than the standard threshold of 25 kg/m², because body fat distribution patterns differ.
• Ashkenazi Jewish individuals have a significantly higher prevalence of BRCA1 and BRCA2 mutations, estimated at 1 in 40 compared to 1 in 400 in the general population, which substantially elevates lifetime breast and ovarian cancer risk and may prompt genetic testing in the 20s or 30s.

Genetic counseling, which is a consultation with a specialist trained to interpret hereditary disease risk, is covered by most major insurers when a patient meets defined criteria such as multiple family members with the same cancer or an unusually young age at diagnosis in a relative.

Ages 18 to 29: Building the Baseline

Screenings in early adulthood focus primarily on infectious disease, reproductive health, and establishing blood pressure and mental health baselines that make future comparisons meaningful.

Chlamydia and gonorrhea screening is notably important because both infections often produce no symptoms yet cause serious reproductive complications if untreated. The USPSTF gives these screenings a Grade B recommendation for all sexually active women under 25.

Blood pressure readings below 120/80 mmHg are considered normal, and establishing that baseline early means any future elevation is measured against a known personal benchmark rather than a population average.

Anxiety screening was added as a USPSTF Grade B recommendation in 2023 for adults aged 18 to 64, making it one of the newest additions to the standard preventive schedule. It uses brief validated tools like the GAD-7 (Generalized Anxiety Disorder 7-item scale, a seven-question self-report questionnaire used to assess anxiety severity) that can be completed in under 3 minutes in a waiting room.

Reproductive and Sexual Health Specifics for Ages 18 to 29

Young adults in this decade carry distinct reproductive health considerations that extend beyond STI testing alone.

• Testicular self-examination: No USPSTF recommendation exists, but the American Cancer Society notes that testicular cancer peaks between ages 15 and 35, and awareness of normal testicular anatomy is clinically useful.
• HPV vaccination: The HPV vaccine, which protects against the strains of human papillomavirus most likely to cause cervical, anal, throat, and penile cancers, is recommended through age 26 for all adults who did not complete the series as adolescents. Adults aged 27 to 45 may receive it after a shared decision-making conversation.
• Preconception counseling: Women planning pregnancy should discuss folic acid supplementation (400 to 800 mcg daily), genetic carrier screening (a blood or saliva test that identifies whether a person carries one copy of a gene mutation associated with inherited conditions like cystic fibrosis or sickle cell disease), and medication safety well before conception.

Ages 30 to 39: Refining the Picture

Testing expands meaningfully in the 30s, particularly for women and for anyone with cardiovascular risk factors that have had a decade to develop.

• Cervical cancer co-testing: At 30, women gain the option to combine the Pap smear with an HPV (human papillomavirus, the virus responsible for most cervical cancers) test every 5 years, replacing the every-3-year Pap smear alone and reducing the total lifetime number of procedures needed.
• Cholesterol (lipid panel): Men should begin cholesterol checks at 35 if they have no risk factors; women at 45. Both groups start at 20 if they have elevated cardiovascular risk, meaning smoking, diabetes, hypertension, or a first-degree relative with heart disease before 55 in men or 65 in women.
• Blood pressure: Anyone with readings at or above 130/80 mmHg should be screened annually and evaluated for hypertension, defined as persistently elevated blood pressure that damages blood vessels over time.
• Diabetes screening: The USPSTF recommends screening all adults aged 35 to 70 who are overweight or obese, using a fasting blood glucose or HbA1c test, which is a blood test that shows average blood sugar over the past 3 months.
• Mental health and substance use: Depression, anxiety, and alcohol misuse screenings remain components of every routine visit throughout this decade.
• Thyroid function: No USPSTF recommendation exists for routine thyroid screening in asymptomatic adults, but women in their 30s with fatigue, weight changes, hair loss, or irregular periods are frequently tested with a TSH (thyroid-stimulating hormone) blood test, as thyroid disorders are significantly more common in women than men.
• BRCA genetic counseling: The USPSTF recommends that primary care providers assess women for BRCA-related cancer risk using a validated risk assessment tool and refer those who screen positive for genetic counseling. This conversation is especially relevant in the 30s for women with affected first-degree relatives.

Important Note: Pregnancy changes screening schedules substantially. Pregnant women receive additional screenings for gestational diabetes between 24 and 28 weeks, hepatitis B, syphilis, anemia, and thyroid disorders, regardless of age.

Cardiovascular Risk Emerging in the 30s

Most people think of heart disease as a concern for their 50s, but arterial plaque, which refers to fatty deposits that build up inside artery walls and narrow blood flow through a process called atherosclerosis, begins accumulating decades earlier. Adults in their 30s who smoke, have diabetes, or have a family history of premature heart disease should have a 10-year cardiovascular risk score calculated using the Pooled Cohort Equations tool, even though statin therapy is typically not initiated until the risk score crosses key thresholds in the 40s.

Maintaining a record of cholesterol, blood pressure, blood sugar, BMI, and smoking status from the 30s onward gives physicians the longitudinal data needed to accurately calculate risk trajectories rather than relying on a single snapshot measurement.

Ages 40 to 49: The Decade That Changes Everything

This decade is arguably the most consequential for preventive medicine in the United States, because several high-mortality cancers become screenable for the first time and cardiovascular risk reaches actionable thresholds for the majority of the population.

Breast Cancer Mammography

The USPSTF updated its recommendation in 2024 to begin mammograms (low-dose breast X-rays that detect tumors too small to feel) at age 40 for average-risk women, a change from its prior 50-year start age. This shift was driven by data showing rising breast cancer incidence in women in their 40s and evidence that earlier screening saves lives despite a higher rate of false positives in younger, denser breast tissue.

Women with a first-degree relative who had breast cancer or who carry BRCA1 or BRCA2 gene mutations should discuss starting as early as age 30 with their provider. Women with extremely dense breast tissue, a finding reported on every mammogram result since the FDA mandated density reporting in 2024, may benefit from supplemental ultrasound or MRI screening in addition to standard mammography.

Breast MRI (magnetic resonance imaging, a scan using magnetic fields rather than radiation to produce detailed soft-tissue images) is recommended annually alongside mammography for women with a 20% or greater lifetime risk of breast cancer as calculated by risk-assessment models. It is covered by most insurers when this threshold is documented.

Colorectal Cancer: Every Option on the Table

Colorectal cancer screening now begins at age 45 for average-risk adults, reduced from the prior start age of 50 by both the USPSTF and the American Cancer Society, reflecting an alarming rise in early-onset colorectal cancer. Patients choose from several screening methods:

1. Colonoscopy (direct visualization of the entire colon using a flexible camera) every 10 years if results are normal
2. Stool DNA test (Cologuard) every 1 to 3 years
3. Annual high-sensitivity fecal immunochemical test (FIT), which detects hidden blood in stool using antibodies specific to human hemoglobin
4. CT colonography (a computed tomography scan of the colon, sometimes called a virtual colonoscopy) every 5 years
5. Flexible sigmoidoscopy (a scope that examines only the lower colon, approximately the final 2 feet of the large intestine) every 5 years, sometimes combined with annual FIT

Each method has different sensitivity, preparation requirements, and follow-up implications. A positive stool-based test always requires a follow-up colonoscopy. Patients with a personal history of colorectal polyps, inflammatory bowel disease (IBD), or a first-degree relative diagnosed with colorectal cancer before 60 should begin colonoscopy screening 10 years before their relative’s diagnosis age, or at 40, whichever is earlier.

Lung Cancer Low-Dose CT

Adults aged 50 to 80 with a 20 pack-year smoking history, meaning one pack per day for 20 years or two packs per day for 10 years, who currently smoke or quit within the past 15 years qualify for annual low-dose computed tomography (LDCT) lung cancer screening. This single recommendation, if applied to all eligible Americans, could prevent an estimated 12,000 lung cancer deaths annually according to the American Lung Association.

Critically, this screening requires a shared decision-making visit, meaning a documented conversation between patient and provider about the benefits, limitations, and potential harms including false positives and incidental findings. Without this documented visit, many insurers will not cover the scan.

Cardiovascular Risk: Statins and Blood Pressure Medications

Adults aged 40 to 75 without prior heart disease or stroke may qualify for statin therapy, a class of medications that lower LDL cholesterol (low-density lipoprotein, sometimes called “bad cholesterol”), if their 10-year cardiovascular risk calculated by the Pooled Cohort Equations tool is 10% or higher. The USPSTF gives this recommendation a Grade B rating for adults in the 40 to 75 age range meeting risk criteria.

Aspirin is no longer routinely recommended for primary prevention in this age group following revised USPSTF guidance published in 2022, because bleeding risks outweigh cardiovascular benefits for most adults who have not already had a cardiac event. Adults who are already taking aspirin for primary prevention should discuss stopping with their physician before discontinuing on their own.

Vision and Dental Health at 40

The American Academy of Ophthalmology (AAO) recommends a comprehensive dilated eye exam, which is an exam where drops widen the pupil to allow full visualization of the retina and optic nerve, starting at age 40 for all adults, with frequency determined by findings. This exam detects glaucoma (a disease that damages the optic nerve, often without any symptoms until significant vision loss has occurred), diabetic retinopathy, and age-related macular degeneration early enough to preserve vision.

Adults with diabetes need a dilated eye exam annually regardless of age, because diabetic retinopathy, which is damage to the blood vessels of the retina caused by chronically elevated blood sugar, is the leading cause of new blindness in working-age Americans.

Ages 50 to 64: Sustaining Momentum

By 50, most major screening programs are actively running, and the focus shifts to maintaining adherence and adjusting intervals based on cumulative test results.

Perimenopause and Menopause-Specific Screenings

Women typically enter perimenopause, which is the transitional period before menopause when estrogen levels begin fluctuating and often begins in the late 40s, and reach menopause (defined as 12 consecutive months without a menstrual period) in their early 50s on average. This hormonal transition has several screening implications that are frequently underdiscussed.

• Bone density baseline: While the formal USPSTF recommendation starts DEXA scans at 65, many clinicians establish a baseline scan at menopause onset because estrogen loss accelerates bone mineral loss by 3 to 5% per year in the first 5 years after menopause.
• Cardiovascular risk recalculation: Estrogen is cardioprotective, meaning it helps maintain healthy cholesterol levels and arterial flexibility. After menopause, women’s cardiovascular risk rises sharply and often surpasses that of age-matched men within 10 years of menopause, the point at which many women first qualify for statin therapy.
• Thyroid function: Hypothyroidism, which is an underactive thyroid condition where the gland does not produce enough hormone and causes fatigue, weight gain, and cold sensitivity, becomes more common in women after menopause, and many providers begin routine TSH testing in this window even in asymptomatic patients.
• Mental health: Depression rates rise during perimenopause and the immediate postmenopausal transition, making depression screening particularly important during this period.

Hepatitis C: The Overlooked Cohort Screening

Adults born between 1945 and 1965, often called the “Baby Boomer cohort,” have a 5 times higher prevalence of hepatitis C virus (HCV) infection than any other age group, largely because HCV was not identified until 1989 and blood supply screening did not begin until 1992. An estimated 75% of Americans living with HCV are in this birth cohort, and the majority do not know they are infected.

Hepatitis C is now curable in more than 95% of cases using direct-acting antivirals (DAA), which are oral medications taken for 8 to 12 weeks with minimal side effects. The USPSTF recommends a one-time HCV antibody test for all adults aged 18 to 79, making this one of the most impactful screenings available for adults currently in their 50s and 60s who have never been tested.

Ages 65 and Older: Protecting What Matters Most

Preventive care at this stage involves screening for conditions that disproportionately affect older adults, including osteoporosis, cognitive decline, vision loss, and fall risk, while continuing cancer surveillance until age thresholds indicate that screening benefits no longer outweigh procedural risks.

Osteoporosis and Fracture Risk

All women beginning at 65 should receive a DEXA scan (dual-energy X-ray absorptiometry, a scan that measures bone mineral density at the hip and spine and compares it to a young adult reference population to produce a T-score). A T-score of -2.5 or lower confirms osteoporosis. A score between -1.0 and -2.5 indicates osteopenia, which is a condition of below-average bone density that is not yet severe enough to classify as osteoporosis but signals elevated fracture risk.

Men with risk factors including low body weight, smoking, long-term steroid use, or a history of fracture warrant DEXA scanning starting around 70. The FRAX tool (Fracture Risk Assessment Tool, a validated calculator developed by the World Health Organization that estimates 10-year fracture probability using clinical risk factors with or without bone density data) can be used by any clinician to determine whether a DEXA scan is warranted before age 65 in women with risk factors.

1 in 2 women and 1 in 4 men over 50 will experience an osteoporosis-related fracture in their lifetime. Hip fractures are particularly serious: 20 to 30% of patients who suffer a hip fracture die within 12 months, most from complications of immobility.

Colorectal Cancer Screening Endpoint Decisions

Screening continues through 75 for most adults. Between 76 and 85, the USPSTF recommends an individualized approach, weighing a patient’s overall health status, life expectancy, and prior screening history. After 85, routine screening is generally not recommended because the average lead time, meaning the number of years a test detects cancer before it would have caused symptoms, for colorectal cancer exceeds remaining life expectancy in most individuals, meaning procedural risk outweighs survival benefit.

Cognitive Screening Nuances

While no formal USPSTF grade exists for dementia screening in asymptomatic adults, the Medicare Annual Wellness Visit includes a mandatory cognitive assessment using provider observation and a standardized tool. Commonly used instruments include:

• Mini-Cog: A 3-minute test involving a three-word recall and clock-drawing task, validated as an effective initial screen in primary care settings
• MMSE (Mini-Mental State Examination): A 10-minute, 30-point standardized assessment of orientation, memory, attention, language, and visuospatial function
• MoCA (Montreal Cognitive Assessment): A 10-minute, 30-point tool considered more sensitive than the MMSE for detecting mild cognitive impairment, which is a stage of memory and thinking decline greater than expected for age but not severe enough to interfere significantly with daily function

Patients who screen positive receive referral for comprehensive neuropsychological evaluation, a detailed battery of cognitive tests administered by a specialist, before any diagnosis of Alzheimer’s disease or other dementia is made.

Fall Prevention: A Screening Category of Its Own

Falls are the leading cause of injury-related death in Americans over 65, and the USPSTF recommends exercise-based fall prevention interventions (rated Grade B) for community-dwelling adults 65 and older who are at increased fall risk. Risk assessment includes evaluating gait speed (the pace at which a person walks, which correlates powerfully with overall health status), balance, medication review, and home hazard evaluation.

Medications that significantly increase fall risk include benzodiazepines (sedative medications used for anxiety and sleep), opioids, certain blood pressure medications that cause orthostatic hypotension (a sudden drop in blood pressure when standing that causes dizziness), and anticholinergic drugs (a class of medications that block a neurotransmitter called acetylcholine and can cause confusion, blurred vision, and unsteady gait). Deprescribing, which is the deliberate and supervised reduction or elimination of medications that no longer provide net benefit, is a critical but underutilized intervention in adults over 65.

Abdominal Aortic Aneurysm

Men aged 65 to 75 who have smoked at least 100 cigarettes in their lifetime should receive a one-time abdominal ultrasound to screen for an abdominal aortic aneurysm (AAA), which is a dangerous bulging or ballooning of the large blood vessel that runs through the abdomen. An AAA that ruptures carries a mortality rate exceeding 80%. The ultrasound itself is painless, requires no preparation, and typically takes under 30 minutes. When an aneurysm is found, its size determines the response: small aneurysms are monitored with periodic ultrasounds, while those exceeding 5.5 cm in diameter typically require surgical repair.

Vaccines as Screening Complements

Immunizations work alongside screenings to prevent diseases that screening cannot catch early enough to cure. Adults of all ages need a Tdap booster every 10 years (which protects against tetanus, diphtheria, and pertussis, also known as whooping cough) and should have completed their COVID-19 primary vaccination series.

Vaccine Schedule by Age Group

Adults aged 65 and older should receive the high-dose or adjuvanted influenza vaccine (formulations designed to produce a stronger immune response in older adults whose immune systems respond less vigorously to standard doses) rather than the standard-dose formulation used for younger adults.

Screening for Conditions Frequently Missed in Standard Checklists

Several conditions with significant health impact are screened for inconsistently in routine primary care, either because awareness is low, referral pathways are unclear, or no USPSTF Grade A or B recommendation currently exists.

Prediabetes and Metabolic Syndrome

Prediabetes (a condition where blood sugar levels are higher than normal but not yet high enough to diagnose type 2 diabetes, defined as an HbA1c between 5.7% and 6.4% or a fasting glucose between 100 and 125 mg/dL) affects an estimated 98 million American adults, and more than 80% of them do not know they have it. Screening adults aged 35 to 70 who are overweight or obese catches most cases, but the ADA recommends that any adult with a BMI above 25 (or 23 for Asian Americans) consider screening regardless of age.

Confirmed prediabetes qualifies a patient for the National Diabetes Prevention Program (NDPP), a CDC-recognized structured lifestyle intervention (a coach-led program of dietary changes and physical activity delivered over 12 months) that reduces progression to type 2 diabetes by 58% in the general population and 71% in adults over 60. Medicare covers the NDPP for eligible beneficiaries.

Nonalcoholic Fatty Liver Disease

Now increasingly called metabolic dysfunction-associated steatotic liver disease (MASLD), this condition occurs when excess fat accumulates in liver cells in people who drink little or no alcohol. It affects an estimated 38% of American adults and is the most common cause of chronic liver disease in the United States. No USPSTF recommendation yet covers routine MASLD screening, but the American Association for the Study of Liver Diseases (AASLD) recommends that adults with obesity or type 2 diabetes be evaluated using a FIB-4 score (a calculation using age, liver enzyme levels, and platelet count that estimates the degree of liver scarring) or abdominal ultrasound.

Identifying MASLD before it progresses to cirrhosis (irreversible liver scarring) or liver cancer is critically important, as FDA-approved treatments for the more advanced form of the disease, MASH (metabolic dysfunction-associated steatohepatitis, a form with liver inflammation and damage on top of fat accumulation), became available beginning in 2024.

Peripheral Artery Disease

PAD (peripheral artery disease) occurs when narrowed arteries reduce blood flow to the legs, causing pain during walking, slow-healing foot sores, and in severe cases limb loss. It affects an estimated 8 to 12 million Americans, disproportionately those over 65, smokers, and people with diabetes. The ankle-brachial index (ABI), a simple non-invasive test that compares blood pressure readings at the ankle and arm to detect arterial narrowing, can be performed in any primary care office in under 15 minutes. The American Heart Association recommends ABI screening for adults over 65 and adults aged 50 to 64 with diabetes or smoking history.

Chronic Kidney Disease

CKD (chronic kidney disease), defined as reduced kidney function persisting for more than 3 months and typically identified by an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73m², which measures how well the kidneys filter waste from the blood, affects an estimated 37 million Americans. Approximately 90% of people with early-stage CKD do not know they have it. Routine urine albumin-to-creatinine ratio (UACR) testing, combined with eGFR measurement from standard metabolic panels, provides a complete CKD screen. The ADA and KDIGO (Kidney Disease: Improving Global Outcomes) guidelines recommend annual CKD screening for all adults with diabetes or hypertension.

Skin Cancer Recognition and Dermatology Referral

The USPSTF currently concludes that the evidence is insufficient to recommend routine whole-body skin examination by a physician for skin cancer in asymptomatic adults. However, melanoma (the deadliest form of skin cancer, arising from melanocytes, the pigment-producing cells in the skin) is highly curable when caught at stage I, with a 5-year survival rate exceeding 98% at that stage, dropping to approximately 30% for stage IV. The American Academy of Dermatology (AAD) recommends annual full-body skin checks by a dermatologist for adults with any of the following:

• A personal or family history of melanoma
• More than 50 moles anywhere on the body
• History of severe or blistering sunburns
• Use of tanning beds at any point in life
• Fair skin, light eyes, or red or blonde hair

Monthly self-examination using the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter larger than a pencil eraser, and Evolution or change over time) is recommended by the AAD for all adults regardless of provider screening status.

Sexually Transmitted Infections Beyond Chlamydia and Gonorrhea

Standard STI screening in the United States focuses heavily on chlamydia and gonorrhea, particularly in young women, but several other infections are significantly underscreened in routine primary care.

• Syphilis: The USPSTF recommends screening for all adults at increased risk, including men who have sex with men and adults with multiple or new sexual partners. Syphilis rates in the United States reached a 70-year high in 2022, with more than 176,000 reported cases.
• Hepatitis B: One-time screening for adults aged 18 to 79 who were not vaccinated or whose vaccination status is unknown is recommended by the USPSTF as a Grade B recommendation issued in 2020.
• Gonorrhea and chlamydia in men: The USPSTF currently finds insufficient evidence to recommend routine STI screening in asymptomatic heterosexual men, but men who have sex with men should be screened at all anatomic sites of exposure (urethra, rectum, throat) at least annually and every 3 to 6 months if at high risk.

Mental Health Screenings Often Left Off the Checklist

Mental health screenings are consistently among the most underperformed preventive services in primary care, despite strong evidence that early identification and intervention meaningfully improve outcomes.

Depression Across the Lifespan

Depression screening is recommended for all adults at every routine visit, using validated tools such as the PHQ-2 (a two-question initial screen asking about low mood and anhedonia, meaning loss of interest or pleasure in activities) and, if positive, the PHQ-9 (a nine-question scale that assesses depression severity and guides treatment decisions). A PHQ-9 score of 10 or higher suggests moderate depression warranting clinical intervention. Both tools are covered under the ACA preventive care mandate at $0 cost sharing.

Anxiety Screening Since 2023

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is the most commonly used validated anxiety screen in primary care. The USPSTF issued a Grade B recommendation for anxiety screening in adults aged 18 to 64 in 2023, making it one of the newest additions to the standard preventive care schedule. Adults 65 and older were not included in this specific recommendation due to insufficient direct evidence in that age group, though many clinicians screen for anxiety in older adults regardless of the gap in formal guidance.

Intimate Partner Violence Screening

The USPSTF recommends screening all women of reproductive age, broadly defined as 18 to 64, for intimate partner violence (IPV), which encompasses physical, sexual, and psychological abuse by a current or former partner, using validated tools such as the HITS screen (Hurt, Insulted, Threatened, Screamed at) or the WAST (Woman Abuse Screening Tool). Positive screens trigger referral to community advocacy resources and safety planning rather than mandatory reporting in most states.

Unhealthy Alcohol and Substance Use

The AUDIT-C (Alcohol Use Disorders Identification Test, Consumption portion, a three-question validated screen for hazardous drinking) is the most widely used brief alcohol screen in primary care. The USPSTF recommends screening and brief behavioral counseling for adults whose drinking exceeds safe limits, defined as more than 4 drinks on any single day or more than 14 drinks per week for men, and more than 3 drinks on any single day or more than 7 drinks per week for women. Screening for opioid use disorder and unhealthy drug use is also recommended using brief validated tools at routine visits, and these services are covered at $0 under the ACA.

Navigating the Preventive vs. Diagnostic Billing Distinction

One of the most consequential practical gaps in patient knowledge involves understanding how the same physical procedure can be billed two entirely different ways with vastly different out-of-pocket costs.

When a colonoscopy is scheduled because a patient is due for routine colorectal cancer screening and reports no symptoms, it is billed as preventive, and the ACA mandates $0 cost sharing. If a polyp is found and removed during that same colonoscopy, some insurers historically reclassified the entire visit as diagnostic and applied deductibles and coinsurance. As of 2023, a federal rule clarified that plans must continue to apply the preventive cost-sharing benefit to the entire colonoscopy even when polyps are removed, though implementation has varied across health plans.

A mammogram ordered because a patient feels a lump is diagnostic and may cost several hundred dollars out of pocket, while a mammogram ordered as part of an annual preventive schedule is $0 under the ACA. The billing code attached to the order, rather than the physical procedure itself, determines patient cost. Patients can request that their provider document the visit as preventive and confirm the billing code before leaving the office.

Understanding this distinction can save patients hundreds to several thousand dollars annually and removes a meaningful financial barrier to maintaining recommended screening intervals.

Scheduling Strategy That Actually Works

Stacking multiple screenings into one annual physical visit reduces the logistical burden of maintaining a full preventive schedule. The Medicare Annual Wellness Visit, available at no cost to Medicare beneficiaries, is specifically designed as a planning appointment where the provider updates a personalized prevention plan, reviews all overdue screenings, and orders referrals in a single session.

Patients who use a patient portal to track due dates, set calendar reminders 6 months in advance of recommended intervals, and bring a running list of family health history to each visit consistently achieve higher screening completion rates than those who rely on provider-initiated reminders alone.

Building a Personal Screening Tracker

A simple tracking document organized by test name, last completion date, next due date, and responsible provider eliminates the common problem of screenings falling through the gaps when a patient sees multiple specialists. Key fields to maintain:

• Last colonoscopy date and polyp findings (determines next interval)
• Last mammogram date and breast density result
• Last Pap and HPV co-test result and year
• Last lipid panel values and current statin status
• Last HbA1c result and prediabetes status
• Last blood pressure reading and trend over time
• DEXA T-score and FRAX 10-year fracture risk calculation
• All vaccine dates and next due dates
• Family history updates reflecting new diagnoses in relatives

The Real Cost of Skipping Screenings

Late-stage colorectal cancer treatment costs an estimated $150,000 to $200,000 or more over the course of care, compared to a colonoscopy that typically costs $2,000 to $3,800 before insurance, with most insured patients paying $0 when performed as preventive care. Stage I breast cancer treatment averages $60,000 to $80,000, while stage IV treatment often exceeds $250,000. Lung cancer caught at stage I through LDCT screening carries a 5-year survival rate above 80%, compared to approximately 6% when caught at stage IV.

Preventive screening schedules represent one of the most powerful, evidence-grounded tools in American medicine. From the first blood pressure check at 18 to the osteoporosis scan at 65 and the ongoing colorectal surveillance through 75, each test reflects decades of population-level research translated into a practical, age-anchored action plan that is within reach of every adult in the United States.

The screenings exist. The insurance coverage, in most cases, exists. The gap is awareness and follow-through, and closing that gap is one of the highest-return investments any American adult can make in their own long-term health.

FAQ’s

What health screenings do I need at age 40?

At age 40, adults should begin mammograms (women), maintain annual blood pressure checks, complete cholesterol testing, and undergo diabetes screening if overweight. Colorectal cancer screening begins at age 45 for average-risk adults, and a dilated eye exam baseline is recommended by the AAO at 40. Talk with your primary care provider to build a personalized list based on family history, smoking status, and BMI.

When should a woman get her first mammogram?

The USPSTF updated its recommendation in 2024 to start mammograms at age 40 for average-risk women, with screening every 2 years thereafter through age 74. Women with a family history of breast cancer, dense breast tissue, or BRCA gene mutations may be advised to start as early as age 30 and to add supplemental MRI screening after a provider risk assessment. The American Cancer Society recommends annual mammography beginning at 45 for average-risk women, with the option to start at 40.

At what age does colonoscopy screening start?

Colorectal cancer screening now begins at age 45 for average-risk adults in the United States, lowered from the prior recommendation of 50 by both the USPSTF and the ACS. Black adults are advised by the American College of Gastroenterology to begin at age 40 given higher incidence and mortality rates in that population. A normal colonoscopy result means the next one is scheduled 10 years later, while a positive stool-based test at any age requires a follow-up colonoscopy.

What blood tests should I get every year?

Annual blood tests commonly recommended for adults include a complete blood count (CBC), comprehensive metabolic panel, lipid panel (cholesterol), and HbA1c (blood sugar average over 3 months). Your doctor may add a TSH thyroid test, liver function tests, or a urine albumin test based on your age, medications, chronic conditions, and risk factors. There is no single universal annual blood panel mandated for all adults by USPSTF guidelines.

What screenings are covered at no cost under the ACA?

The Affordable Care Act requires most private health plans to cover preventive services rated “A” or “B” by the USPSTF at $0 cost sharing when performed as preventive care, with no copay or deductible applied. This includes blood pressure checks, mammograms, colonoscopies, cervical cancer Pap smears, HIV tests, anxiety and depression screenings, alcohol misuse counseling, and diabetes screening for eligible adults. Tests ordered to investigate a symptom are coded as diagnostic and are subject to your plan’s deductibles and copays regardless of what the procedure physically involves.

How often should adults get their blood pressure checked?

Adults with normal blood pressure below 120/80 mmHg should be checked at least every 2 years. Those with readings between 120/80 and 129/80 mmHg (elevated) should recheck annually, and anyone with consistent readings at or above 130/80 mmHg may receive a hypertension diagnosis requiring more frequent monitoring and possible treatment. Blood pressure can be checked at a provider visit, pharmacy kiosk, or with a validated home monitor, and home readings should be brought to each annual visit.

When should men get a prostate cancer screening?

The USPSTF gives PSA (prostate-specific antigen) testing a Grade C recommendation for men aged 55 to 69, meaning it should be an individual decision made after discussing the benefits and harms, including false positives and unnecessary biopsies, with a doctor. Men with a first-degree relative diagnosed with prostate cancer before 65, or Black men who carry a statistically higher incidence risk, should begin this conversation at 40 to 45. PSA testing is generally not recommended after age 70 for average-risk men.

What is the recommended age to stop cervical cancer screenings?

Women who have had adequate prior cervical cancer screenings with consistently normal results can stop Pap smear and HPV testing at age 65. Adequate prior screening means three consecutive normal Pap smears or two consecutive normal co-tests within the past 10 years, with the most recent test within the past 5 years. Women who have never been regularly screened should not stop at 65 and should discuss an appropriate stopping point individually with their provider.

Does Medicare cover preventive screenings at no cost?

Medicare Part B covers many USPSTF-recommended preventive screenings at no cost to the beneficiary, including annual mammograms for women over 40, colorectal cancer screenings starting at 45, bone density scans for women at risk, cardiovascular screenings, and depression and alcohol misuse screening. The Medicare Annual Wellness Visit, available free once per year after the first 12 months of Part B enrollment, is specifically designed to coordinate and update a personalized prevention plan, review all overdue tests, and issue referrals during a single appointment.

What health tests do men need in their 50s?

Men in their 50s should maintain annual blood pressure and cholesterol checks, complete colorectal cancer screening beginning at 45, and undergo diabetes screening every 3 years if overweight or obese. Those with a 20 pack-year smoking history who currently smoke or quit within the past 15 years qualify for annual lung cancer LDCT scans starting at 50, which requires a documented shared decision-making visit. A conversation about PSA prostate cancer testing for men aged 55 to 69 is also appropriate during this decade.

How do I know if I need earlier screenings due to family history?

A first-degree relative who had colorectal cancer or polyps before 60 should prompt starting colonoscopy screening 10 years before that relative’s age at diagnosis, or at 40, whichever is earlier. A close family history of breast, ovarian, or heart disease typically moves recommended start ages earlier and may qualify a patient for genetic counseling covered at $0 under the ACA. Bringing a written family health history that includes diagnosis ages and relationships to every annual visit gives your provider the data needed to apply the correct risk-adjusted schedule.

What screenings are recommended specifically for adults over 65?

Adults over 65 should receive DEXA bone density scans (women at 65; men with risk factors around 70), continue annual blood pressure and cholesterol checks, maintain colorectal cancer screening through 75, complete a one-time hepatitis C test if not previously done, receive Shingrix (two doses), PCV20 pneumococcal vaccine, and high-dose influenza vaccine annually, and participate in fall risk assessment and cognitive screening at their Medicare Annual Wellness Visit. Men aged 65 to 75 with a smoking history of at least 100 cigarettes should also receive a one-time abdominal aortic aneurysm ultrasound, covered at $0 by Medicare.

What is prediabetes and how is it screened?

Prediabetes is a condition where blood sugar levels are above normal but below the diabetes threshold, defined as an HbA1c between 5.7% and 6.4% or a fasting glucose between 100 and 125 mg/dL. It affects an estimated 98 million U.S. adults, and more than 80% do not know they have it. The USPSTF recommends screening adults aged 35 to 70 who are overweight or obese, and a confirmed prediabetes diagnosis qualifies a patient for the CDC-recognized National Diabetes Prevention Program, which reduces diabetes progression by 58% over 12 months.

What mental health screenings should be included in a routine checkup?

Routine checkups should include depression screening using the PHQ-2 and PHQ-9 for all adults, anxiety screening using the GAD-7 for adults aged 18 to 64 per the 2023 USPSTF Grade B recommendation, and alcohol misuse screening using the AUDIT-C for all adults. Women of reproductive age should also receive screening for intimate partner violence using a validated tool such as the HITS screen. All of these screenings are covered at $0 under the ACA when performed as part of a preventive visit.

What is the difference between preventive and diagnostic billing for screenings?

Preventive billing applies when a test is ordered as part of a scheduled screening program for a patient with no symptoms, triggering $0 cost sharing under the ACA for all covered USPSTF-rated services. Diagnostic billing applies when the same test is ordered in response to a reported symptom or known abnormal finding, and it is then subject to your plan’s deductibles and coinsurance regardless of the procedure itself. A 2023 federal rule clarified that colonoscopies must retain preventive billing status even when polyps are removed during the procedure, and patients should confirm billing codes with their provider before any procedure when cost is a concern.

How do race and ethnicity affect my recommended screening schedule?

Several key screening start ages differ meaningfully by racial and ethnic background due to documented variation in disease incidence and underlying risk. Black adults are advised to begin colorectal cancer screening at 40 rather than 45, and Black women face a 40% higher breast cancer mortality rate warranting discussion of earlier or more frequent mammography with their provider. Asian Americans should be screened for diabetes at a BMI of 23 kg/m² rather than 25, and Ashkenazi Jewish individuals have a 1 in 40 prevalence of BRCA mutations compared to 1 in 400 in the general population, making genetic counseling referral especially relevant during routine care.